New Aleve formulation
This article was originally published in The Tan Sheet
Liquid Gels target active consumers ages 25 to 49 who suffer from back and joint pain, according to Bayer HealthCare. Available now in food, drug and mass retail outlets, Liquid Gels combine the all-day pain relieving power of Aleve (naproxen sodium) with "liquid-fast" speed and convenient dosing, according to the company. "Just two Aleve Liquid Gels can provide this all-day relief, where it would take four or even eight pills with other brands," the firm claims. The gels are sold in 20-, 40-, 80- and 160-count sizes, with suggested retail prices starting at $5.49...
You may also be interested in...
Perrigo launches Aleve generic
Artificial intelligence model’s comments signal the likely start of computer-generated comments to the US FDA’s public notices.
Pink Sheet Podcast: US FDA Loses Gene Therapy Expert, Humira Biosimilars Launch, FDA Allows In-Person Meetings
Pink Sheet reporters and editors consider the impact of FDA Office of Tissues and Advanced Therapies Director Wilson Bryan’s retirement, the launch of Humira biosimilars and its effect on the biologic market, as well as the FDA moving to hybrid meetings with sponsors.